Pyridazine Compounds as NLRP3 Inhibitors for Treating Parkinson’s Disease or Frontotemporal Dementia

ACS Medicinal Chemistry Letters, Journal Year: 2024, Volume and Issue: 15(12), P. 2083 - 2084

Published: Nov. 7, 2024

Provided herein are novel pyridazine compounds as NLRP3 inhibitors, pharmaceutical compositions, use of such in treating Parkinson's disease or frontotemporal dementia, and processes for preparing compounds.

Language: Английский

Novel Triazines as NLRP3 Inhibitors for Treating Multiple Diseases

ACS Medicinal Chemistry Letters, Journal Year: 2024, Volume and Issue: 15(12), P. 2099 - 2100

Published: Nov. 18, 2024

Provided herein are novel triazines as NLRP3 inhibitors, pharmaceutical compositions, use of such compounds in treating multiple diseases, and processes for preparing compounds.

Language: Английский